Avance Clinical News

  1. Australia Delivers Certainty For US Biotechs In 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, And R&D Rebates 5/28/2025

    As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.

  2. Meet With Avance Clinical At ASCO 2025 In Chicago 5/20/2025

    Avance Clinical will attend and host a booth at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled from May 30 to June 3, 2025, at McCormick Place in Chicago, Illinois. This premier event brings together oncology professionals from around the world to connect, collaborate, and inspire advancements in cancer care.

  3. Avance Clinical Honored With Frost & Sullivan's 2025 Global Customer Value Leadership Award 5/20/2025

    Frost & Sullivan has named Avance Clinical the recipient of its 2025 Global Customer Value Leadership Award in the biotech contract research organization (CRO) sector, highlighting the company’s outstanding performance in delivering exceptional client value through innovation, service excellence, and technology-enabled trial optimization.

  4. Avance Clinical To Showcase Asia-Pacific Clinical Trial Expertise At BIO Korea 2025 4/15/2025

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.

  5. Global Reach For Biotechs: Avance Clinical Secures MOUs With Four Premier Taiwanese Trial Sites 3/24/2025

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.

  6. Avance Clinical Expands In Asia With Taipei Office To Accelerate Biotech Clinical Trials 3/24/2025

    Avance Clinical, the award-winning, full-service Contract Research Organization (CRO) specializing in delivering agile and accelerated clinical development solutions for global biotechs, has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.

  7. Simbec-Orion And Avance Clinical Consolidates Partnership With Memorandum Of Understanding 3/4/2025
  8. Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025 1/14/2025

    Wake Forest, NC, USA | Adelaide, Australia

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.

    Book a meeting with the Avance Clinical team at Biotech Showcase.

  9. Avance Clinical Wins Premier's Business And Export Awards 2024 11/26/2024

    Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony. 

  10. Avance Clinical Recognized As Finalist In 62nd Australian Export Awards For International Health 11/26/2024

    Avance Clinical, a leading Australian Contract Research Organization (CRO), has been named a finalist in the prestigious 62nd Australian Export Awards, under the International Health category. This recognition highlights the company’s exceptional contributions to the global biotechnology sector, supported by its reputation for delivering high-quality data, fast clinical trial timelines, and innovative clinical trial solutions.